FOXD3 Antibody, HRP conjugated

1. FOXD3 acts as a repressor of the mitochondrial S-adenosylmethionine carrier (SLC25A26) gene expression in cancer cells. PMID: 30076902
2. On the basis of these data, FOXD3 is a potent repressor of DCLK1-S expression in normal cells; loss of FOXD3 in hCCCs/hCRCs allows upregulation of DCLK1-S, imparting a potent invasive potential to the cells PMID: 28851816
3. FOXD3 knockdown resulted in enhanced ATC proliferation, invasion and migration and diminished cellular apoptosis. Further, we showed that FOXD3 regulated expression of E-cadherin by modulating MAPK/EKR signaling pathway that promotes EMT and metastasis during thyroid carcinogenesis. PMID: 28430585
4. Results show that FOXD3 expression was reduced in colon cancer cells. Its knockdown dramatically increased the proliferation of tumor cells, enhanced cell invasiveness and inhibited cell apoptosis. The study indicates that FOXD3 may play a protective role in human colon formation by regulating EGFR/Ras/Raf/MEK/ERK signal pathway. PMID: 27926503
5. FOXO4 and FOXD3 were shown independently predictive of overall survival in gastric cancer PMID: 27027443
6. FOXD3/miR-214/MED19 axis is important for the regulation of growth, invasion and metastasis of colorectal cancer PMID: 27811858
7. total of 1799 differentially methylated regions were identified including SLC6A3, Rab40C, ZNF584, and FOXD3 whose significant methylation differences were confirmed in breast cancer patients through quantitative real-time polymerase chain reaction.Methylation of those aforementioned genes in white blood cells of our young patients may highlight their potential as early epimarkers PMID: 28349825
8. Results showed that silencing FoxD3 in lung cancer cell lines stimulated cell growth and inhibited cell apoptosis. PMID: 25894280
9. FOXD3 is sufficient but not necessary to drive PAX3 expression in melanoma cells. PMID: 26252164
10. The present study finds that the aspirin-FOXD3-OLA1P2-STAT3 axis exhibits exciting anticancer effects and provides new insights into the chemopreventive mechanisms underlying aspirin use PMID: 26898989
11. FOXD3 might serve as an independent prognostic biomarker and a potential therapeutic target for high-grade gliomas, which warrant further investigation. PMID: 26011451
12. Down-regulation of FOXD3 is associated with metastasis in hepatocellular carcinoma. PMID: 26112097
13. Data show that transcription factors PAX3 and FOXD3-mediated melanoma cell migration is dependent on promoting the expression of chemokine receptor CXCR4. PMID: 26205821
14. In addition to a possible association of rs78645479 in FoxD3 with vitiligo, our data on the association of this FoxD3 variant with thyroid autoantibodies suggest a potential involvement of FoxD3 in thyroid immunoregulation. PMID: 26267147
15. FOXD3 overexpression significantly inhibits cell growth and results in G1 cell cycle arrest in NSCLC A549 and H1299 cells. PMID: 26341266
16. FOXD3 and TWIST1 define distinct subgroups of cells within a heterogeneous tumor. PMID: 25061102
17. Findings indicate that miR-137 is a valuable biomarker for hepatocellular carcinoma (HCC) prognosis and the forkhead box D3 (FoxD3)/miR-137/AKT2 regulatory network plays an important role in HCC progression. PMID: 24970808
18. Results suggest an inverse relationship between FoxD3 expression and tumor metastasis in invasive ductal carcinomas of the breast. PMID: 24551288
19. Results indicate that FOXD3 exhibits tumor suppressive activity that affects the growth, aggressiveness and angiogenesis of NB through transcriptional regulation of NDRG1. PMID: 24269992
20. Our results indicate FOXD3 exhibits tumor suppressive activity and may be useful for breast therapy. PMID: 24632201
21. Foxd3 is both sufficient and necessary for regulating the balance between melanocyte and Schwann cell development. In addition, Foxd3 is also sufficient to regulate the switch between neuronal and glial fates in sensory ganglia. PMID: 23858437
22. upregulation of ERBB3 is involved in melanoma adapting to RAF/MEK inhibitors through FOXD3 PMID: 23543055
23. Methylation profile analyses identified the promoter of FOXD3 as the only genomic region with increased methylation in mice and humans during progression of Helicobacter pylori-associated gastric tumors. PMID: 23058321
24. A balance of FOXD3 activity is required to maintain pluripotency and paraxial mesoderm fates. PMID: 22887036
25. Six nonsynonymous FOXD3 variants were identified in human ocular disease. PMID: 22815627
26. FOXD3 regulates migration properties and Rnd3 expression in melanoma cells PMID: 21478267
27. Studies show FOXD3 is suppressed by B-RAF, uncover a novel role and mechanism for FOXD3 as a negative cell cycle regulator, and have implications for the repression of melanocytic lineage cells. PMID: 20332228
28. candidate for vitilago susceptibility and autosomal dominant with promoter variation PMID: 16098053
29. HIV-1 induces OTK18 expression through a YIN-YANG-1 mediated manner in human macrophages, although its gene expression is suppressed by FoxD3 upregulation PMID: 19034670

Show More

Hide All

HGNC: 3804

OMIM: 607836

KEGG: hsa:27022

STRING: 9606.ENSP00000360157

UniGene: Hs.546573